Tixel treatment for symptoms of dry eye disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the effects of Tixel treatment, a thermo-mechanical action based peri-orbital fractional skin treatment, compared to a sham treatment on patients with Dry Eye Disease. Participants will be assessed for symptoms and signs of the condition, focusing on those with mild to moderate periorbital wrinkles and specific eye health criteria. The study aims to determine if Tixel treatment can provide significant relief from dry eye symptoms.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Mild to Moderate Periorbital wrinkles
2. OSDI score of at least 23
3. Noninvasive Tear film break up time (NIBUT) ≤ 10 seconds
4. No other eye or skin or immune problems
5. Willing and able to provide written informed consent.
6. Willing to participate in all study activities and instructions.

Exclusion Criteria:

1. Pregnancy and/or breastfeeding
2. Lesions in the periorbital area
3. Acute severe blepharitis
4. Acute conjunctivitis
5. Use of eye drops within 2 hours before examination
6. Other concomitant anterior eye disease
7. Has undergone outdoors/sunbed tanning during the last 4 weeks
8. Is unwilling to follow the Tixel aftercare instructions after each of the three Tixel treatments.
9. Active Herpes Simplex or tendency for Herpes Simplex in the periorbital area (meaning the subject has had the condition previously).
10. Current skin cancer, malignant sites and/or advanced premalignant lesions or moles in the treatment area.
11. An impaired immune system condition or use of immunosuppressive medication.
12. Collagen disorders, keloid formation and/or abnormal wound healing.
13. Previous invasive/ablative procedures in the areas to be treated within 3 months prior to initial treatment or plans for such treatment during the course of the Tixel2 device treatment, or before complete healing of such treatments has occurred.
14. Any patient who takes or has taken any medications (including via topical application), herbal treatment (oral or topic), food supplements or vitamins, which may cause fragile skin or impaired skin healing during the last 3 months.
15. Any patient who has used oral Isotretinoin (Accutane® or Roaccutan®) within 3 months prior to treatment or less.
16. Any patient who has a history of bleeding coagulopathies or use of anticoagulants.
17. Any patient who has tattoos or permanent makeup in the treated area.
18. Any patient who has burned skin, blistered skin, irritated skin, or sensitive skin in any of the areas to be treated.
19. Any patient who underwent thread lifting of the area to be treated in the last 3 months.

Where it's running

• Vision Science, School of Optometry
  Birmingham, United Kingdom Recruiting

Study contacts

• Study coordinator: Sunil Shah, MD
• Email: s.shah26@aston.ac.uk
• Phone: +44 121 711 2020

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Can cyclosporine 0.1% eye drops improve comfort for contact lens wearers with dry eye

  This study tests whether a water-free cyclosporine eye drop (VEVYE) can reduce dry eye symptoms and improve comfort for adults who wear soft contact lenses.

  Recruiting Ocular Aesthetics, LLC dba Ocular Clinical Trials · Houston, Texas · NCT07904728

• Association Between Periodontitis and Dry Eye Disease in Adults

  This study tests whether periodontitis and dry eye disease are linked by comparing groups with and without each condition.

  Recruiting University of Sulaimani · Sulaymaniyah, As Sulaymaniyah Governorate · NCT07873697

• Brillouin hydration mapping to study cornea health

  Researchers test a Brillouin microscope to see if it can measure corneal water content in healthy people and those with eye conditions.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07780890

• Is Systane PRO Preservative Free as good as Blink Triple Care Preservative Free for dry eye symptoms

  This study tests whether Systane PRO Preservative Free works as well as Blink Triple Care Preservative Free to improve dry eye symptoms in adults over 4 weeks.

  Recruiting Phase 4 Gordon Schanzlin New Vision · La Jolla, California · NCT07745062

• TRYPTYR eye drops for dry eye disease

  This study tests TRYPTYR eye drops to see if they improve dry eye symptoms in adults with Dry Eye Disease.

  Recruiting Phase 4 NYU Langone Health · New York, New York · NCT07732010

• OTC lubricating eye drops for dry eye disease: tolerability and vision outcomes

  This trial tests whether a preservative-free OTC eye drop mix can be tolerated and improve symptoms and visual comfort in adults with dry eye disease.

  Recruiting Phase 4 Andover Research Eye Institute · Andover, Massachusetts · NCT07676084

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.